Effects of Garcinia cambogia (Hydroxycitric Acid) on Visceral Fat Accumulation: A Double-Blind, Randomized, Placebo-Controlled Trial

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 8, 2003, Pages 551-567

  Hayamizu, Kohsuke ^a,b   Ishii, Yuri ^a   Kaneko, Izuru ^a   Shen, Manzhen ^a   Okuhara, Yasuhide ^a   Shigematsu, Norihiro ^a   Tomi, Hironori ^c   Furuse, Mitsuhiro ^b   Yoshino, Gen ^d   Shimasaki, Hiroyuki ^e  

^a Central Research Development Laboratory Fancl Corporation   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NIPPON SHINYAKU CO LTD   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

Author keywords

Computed tomography scan; Garcinia cambogia; Hydroxycitric acid; Visceral fat accumulation

Indexed keywords

GARCINIA CAMBOGIA EXTRACT; HYDROXYCITRIC ACID; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GARCINIA CAMBOGIA; HEADACHE; HEIGHT; HUMAN; LABORATORY TEST; LIPID STORAGE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TOOTH PAIN; TRIACYLGLYCEROL BLOOD LEVEL; UMBILICUS;

EID: 0344945600     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2003.08.006     Document Type: Article

References (34)

1. Ministry of Health, Labour and Welfare Japan. The National Nutrition Survey in Japan 2000. Tokyo, Japan: Dai-ichi Shuppan Publishing; 2002:59-60.
2. Déspres JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137-159.
3. Bray GA. Complications of obesity. Ann Intern Med. 1985;103:1052-1062.
4. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985;103:1073-1077.
5. Kissebah AH, Freedman DS, Peiris AN. Health risks of obesity. Med Clin North Am. 1989;73:111-138.
6. Van Itallie TB. Obesity: Adverse effects on health and longevity. Am J Clin Nutr. 1979;32(Suppl 12):2723-2733.
7. Larsson B, Bjorntorp P, Tibblin G. The health consequences of moderate obesity. Int J Obes. 1981;5:97-116.
8. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA. 1987;257:353-358.
9. Seidell JC, Verschuren WM, van Leer EM, Kromhout D. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med. 1996;156:958-963.
10. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
11. Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372-1379.
12. Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978;240:1607-1610.
13. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985;103:983-988.
14. Saito Y, ed. Manual for the Treatment of Obesity. Tokyo, Japan: Ishiyaku Publishers; 2001:22-28.
15. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994;107:239-246.
16. Matsuzawa Y, Shimomura I, Nakamura T, et al. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res. 1995;3(Suppl 2):187S-194S.
17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
18. Keno Y, Matsuzawa Y, Tokunaga K, et al. High sucrose diet increases visceral fat accumulation in VMH-lesioned obese rats. Int J Obes. 1991;15:205-211.
19. Lewis YS, Neelakantan S. (-)-Hydroxycitric acid - the principal acid in the fruits of Garcinia cambogia desr. Phytochemistry. 1965;4:619-625.
20. Watson JA, Lowenstein JM. Citrate and the conversion of carbohydrate into fat. Fatty acid synthesis by a combination of cytoplasm and mitochondria. J Biol Chem. 1970;245:5993-6002.
21. Watson JA, Fang M, Lowenstein JM. Tricarballylate and hydroxycitrate: Substrate and inhibitor of ATP: Citrate oxaloacetate lyase. Arch Biochem Biophys. 1969;135:209-217.
22. Sullivan AC, Singh M, Srere PA, Glusker JP. Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase. J Biol Chem. 1977;252:7583-7590.
23. Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem. 1971;246:629-632.
24. Sullivan AC, Triscari J, Hamilton JG, et al. Effect of (-) -hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids. 1974;9:121-128.
25. Sullivan AC, Triscari J, Hamilton JG, Miller ON. Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids. 1974;9:129-134.
26. Sullivan C, Triscari J. Metabolic regulation as a control for lipid disorders. I. Influence of (-)-hydroxycitrate on experimentally induced obesity in the rodent. Am J Clin Nutr. 1977;30:767-776.
27. Berkhout TA, Havekes LM, Pearce NJ, Groot PH. The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2. Biochem J. 1990; 272:181-186.
28. Conte AA. A non-prescription alternative in weight reduction therapy. Am J Bariatr Med Summer. 1993;17-19.
29. Thom E. Hydroxycitrate (HCA) in the treatment of obesity. Int J Obes. 1996;20 (Suppl 4):48.
30. Rothacker DQ, Waitman BE. Effectiveness of a Garcinia cambogia and natural caffeine combination in weight loss: A double-blind, placebo-controlled pilot study. Int J Obes. 1997;21(Suppl 2):53.
31. Sawada H, Tomi H, Tamura K, et al. Effect of liquid Garcinia extract and soluble Garcinia powder on body weight change: A possible material for suppressing fat accumulation. Jpn Oil Chem Soc. 1997;46:1467-1474.
32. Hayamizu K, Ishii Y, Kaneko I, et al. Effects of long-term administration of Garcinia cambogia extract on visceral fat accumulation in humans: A placebo-controlled double blind trial. J Oleo Sci. 2001;50:805-812.
33. The Ministry of Health and Welfare. 6th Recommended Dietary Allowances for the Japanese. Tokyo, Japan: Dai-ichi Shuppan Publishing; 1999:36-41.
34. Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: A randomized controlled trial. JAMA. 1998;280: 1596-1600.